ArticleHealth science reports2026
Comparison of AGA and SGA Infants Based on Prooxidant-to-Antioxidant Balance in Mashhad, Iran During 2019-2025: A Cross-Sectional Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Small for Gestational Age (SGA) infants face numerous challenges that may stem from a prooxidant-antioxidant imbalance. This study aims to compare AGA and SGA infants regarding their PAB (Prooxidant-Antioxidant Balance) levels. Methods: This cross-sectional study was conducted on 898 neonates, including 798 (88.9%) appropriate for gestational age (AGA) infants and 100 (11.1%) small for gestational age (SGA) infants. The research utilized convenience sampling at Ghaem Hospital in Mashhad, spanning from 2019 to 2025. Data were collected using a questionnaire developed by the researchers, which consisted of three sections: neonatal information (including gestational age, first-minute Apgar score, fifth-minute Apgar score, and birth weight) and laboratory information (including umbilical cord pH and neonatal PAB levels). The SGA infants were classified as the case group, while the AGA infants served as the control group. The study compared PAB levels and neonatal outcomes-including asphyxia, retinopathy of prematurity (ROP), necrotizing enterocolitis (NEC), patent ductus arteriosus (PDA), and sepsis-between the two groups. Results: The mean gestational age for the AGA group was 34.29 ± 4.31 weeks, while the mean gestational age for the SGA group was 34.75 ± 2.63 weeks. The 1-min Apgar score showed significant differences, with a Conclusion: The current study's results show that PAB levels are higher in SGA infants compared to AGA infants. Additionally, instances of ROP, and NEC were more prevalent in the SGA group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.